1. Evaluation of antimicrobial purchasing by companion animal veterinary facilities in Canada, the United Kingdom, and the United States of America (2019‐2021)
- Author
-
J. Scott Weese, Margo Mosher, Rochelle Low, Ellie West, Ben O'Kelley, Jo Ann Morrison, Anne Kimmerlein, Silene St. Bernard, Kathrine Blackie, Ulrika Gronlund, and Ian Battersby
- Subjects
antimicrobial resistance ,antimicrobial stewardship ,epidemiology ,infectious diseases ,microbiology ,surveillance ,Veterinary medicine ,SF600-1100 - Abstract
Abstract Background Measuring antimicrobial use is a core component of antimicrobial stewardship. Purchasing data may be easier to obtain than prescription data in some situations, but differences in clinic size, caseload and collection timeframes must be considered. Objective Our objective was to evaluate purchases of systemic antibacterial agents by small animal veterinary facilities in 5 networks across 3 countries, using a mg/veterinarian full time equivalent (FTE)/week as the metric. Methods Data were obtained from purchasing records of 2194 veterinary facilities from networks from the United States (US, n = 3: US‐A, 1036 facilities; US‐B, 101 facilities; US‐C, 886 facilities), Canada (n = 1: 117 facilities) and the United Kingdom (UK, n = 1: 54 facilities) during 2019‐2021. Results In total, 20 020 269 767 mg (20.02 t) of antimicrobials were purchased. Overall differences between the UK and North America were driven by significantly higher purchases of amoxicillin‐clavulanic acid in the UK (P
- Published
- 2024
- Full Text
- View/download PDF